The account--elilillyco--has posted old photographs of Lilly's facilities and researchers alongside pictures of what its current staff are doing.
Over the past decade a plethora of digital formats have begun competing with print, television, radio and conferences for biopharma marketeers' budgets. And while initial uptake was slow, a survey has now found Big Data, social media and mobile have doubled their share of the marketing mix since 2012.
Pfizer CEO Ian Read has become the first pharma executive to contribute an article to LinkedIn's publishing platform.
Chinese police have detained a man for allegedly spreading false bird flu rumors on social media, Reuters reports.
Which pharma companies are getting it right when it comes to social media? As far as Twitter is concerned, Boehringer Ingelheim is up there.
Biopharma has encountered more critics than cheerleaders as it has cautiously edged into social media, but Boehringer Ingelheim has recently won a high-profile supporter: Twitter. In a case study, the social network praised Boehringer's use of its platform.
Inherent conservatism and a lack of regulatory guidance have caused pharma to edge slowly onto social media platforms. Yet patients still talk about their health online. Should drugmakers be listening?
It's no revelation that pharma is behind the curve when it comes to social media. Consider yourselves fortunate, then, that the IMS Institute for Healthcare Informatics chose to delve into the subject. Its new report makes the case for social media--complete with the sort of statistics you'd want for your own memos to the powers that be.
With the deadline for publication of long-awaited FDA guidance on online drug promotion now just 6 months away, the FDA has got the ball rolling early, posting an unexpected document outlining its views on how and when companies should submit online promotional materials for review.
Medtronic CEO Omar Ishrak has already been feted with praise for his efforts to keep the world's largest medical device company on the cutting edge, but a team of researchers are looking into the effects of one the GE veteran's less-discussed attributes: his ego.